<DOC>
	<DOCNO>NCT02900027</DOCNO>
	<brief_summary>The purpose ass safety , tolerability , pharmacokinetics , pharmacodynamics IONIS APOC-III-LRx give healthy volunteer subject .</brief_summary>
	<brief_title>Safety , Tolerability , PK , Pharmacodynamics ( PD ) IONIS APOCIII-LRx Healthy Volunteers With Elevated Triglycerides</brief_title>
	<detailed_description />
	<mesh_term>Hypertriglyceridemia</mesh_term>
	<criteria>Must give write informed consent able comply study requirement Healthy male female age 1865 inclusive Females must nonpregnant nonlactating , either surgically sterile post menopausal Males must surgically sterile , abstinent use acceptable contraceptive method BMI &lt; 35.0 kg/m2 Subjects must Fasting TG ≥ 90 mg/dL ≥ 200 mg/dL depend Cohort assignment Known history positive test human immunodeficiency virus ( HIV ) , hepatitis C chronic hepatitis B Treatment another Study Drug , biological agent , device within onemonth screen Regular excessive use alcohol within 6 month Screening Use concomitant drug unless authorize Sponsor Medical Monitor Smoking &gt; 10 cigarette day Considered unsuitable inclusion Principal Investigator</criteria>
	<gender>All</gender>
	<minimum_age>18 Years</minimum_age>
	<maximum_age>65 Years</maximum_age>
	<verification_date>February 2017</verification_date>
</DOC>